(MT Newswires) -- Dutch Philips Group (PHG) CEO Roy Jakobs discusses the consequences of the sleep apnea machine recall. The Dutch medical equipment manufacturer has not given a definitive figure for the cost of the recall, as the legal proceedings are not over, but claims that 99% of defective devices have been replaced. While the company has recorded three consecutive quarters of growth, it points to investments in artificial intelligence, estimated at over a billion euros a year.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
25.11 EUR | -1.68% | +28.06% | +19.04% |
01:37pm | PHILIPS NV : Goldman Sachs maintains a Buy rating | ZD |
01:34pm | PHILIPS NV : Deutsche Bank withdraws its Sell rating | ZD |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.04% | 24.75B | |
+8.69% | 220B | |
+6.69% | 183B | |
+10.90% | 133B | |
+25.41% | 107B | |
-0.68% | 63.05B | |
+12.72% | 51.74B | |
+3.96% | 50.47B | |
+0.40% | 40.91B | |
+15.03% | 40.59B |
- Stock Market
- Equities
- PHIA Stock
- News Philips NV
- Product recalls, renewed growth, investment in AI. Roy Jakobs, Philips CEO